| |
| |
|
| Insider
Information: |
Mazzo David J |
| Relationship: |
Chief Executive Office... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
711,243 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$163,057 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
711,243 |
|
|
| Total
Value |
$163,057 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avanir Pharmaceuticals |
AVNR |
Director |
2014-02-12 |
336,394 |
2006-02-13 |
0 |
Premium* |
|
|
EyePoint Pharmaceuticals Inc |
EYPT |
|
2019-10-09 |
200,083 |
|
0 |
Premium* |
|
|
Lisata Therapeutics Ord Shs |
LSTA |
Chief Executive Office... |
2024-01-11 |
174,766 |
2015-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2024-01-11 |
4 |
D |
$2.99 |
$3,068 |
D/D |
(1,026) |
174,766 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2024-01-10 |
4 |
D |
$3.00 |
$10,410 |
D/D |
(3,470) |
175,792 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2024-01-09 |
4 |
D |
$3.08 |
$61,742 |
D/D |
(20,046) |
179,262 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2024-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
94,000 |
199,308 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2023-01-13 |
4 |
D |
$3.65 |
$1,449 |
D/D |
(397) |
96,543 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2023-01-11 |
4 |
D |
$3.20 |
$3,296 |
D/D |
(1,030) |
96,940 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2023-01-10 |
4 |
D |
$3.20 |
$11,087 |
D/D |
(3,470) |
97,970 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2023-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
109,285 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2023-01-09 |
4 |
D |
$3.00 |
$23,535 |
D/D |
(7,845) |
101,440 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2022-09-01 |
4 |
D |
$0.50 |
$34,871 |
D/D |
(69,742) |
739,444 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2022-09-01 |
4 |
A |
$0.50 |
$75,000 |
D/D |
150,000 |
809,186 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2022-01-14 |
4 |
D |
$0.82 |
$5,424 |
D/D |
(6,611) |
631,065 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2022-01-13 |
4 |
D |
$0.81 |
$5,218 |
D/D |
(6,471) |
637,676 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2022-01-11 |
4 |
D |
$0.87 |
$14,482 |
D/D |
(16,740) |
644,147 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2022-01-10 |
4 |
D |
$0.92 |
$51,728 |
D/D |
(56,410) |
660,887 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2022-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
401,000 |
717,297 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2021-01-14 |
4 |
D |
$1.56 |
$9,260 |
D/D |
(5,936) |
299,505 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2021-01-13 |
4 |
D |
$1.55 |
$43,729 |
D/D |
(28,212) |
305,441 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2021-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
39,000 |
333,653 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2021-01-11 |
4 |
D |
$1.59 |
$26,427 |
D/D |
(16,621) |
294,653 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2021-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
119,000 |
311,274 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2021-01-08 |
4 |
D |
$1.60 |
$7,562 |
D/D |
(4,726) |
192,274 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chief Executive Officer |
• • – |
2020-01-08 |
4 |
D |
$2.83 |
$12,797 |
D/D |
(4,522) |
153,010 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
|
– • – |
2019-10-09 |
4 |
OE |
$1.95 |
$64,999 |
D/D |
33,333 |
200,083 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
|
– • – |
2019-09-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
417 |
166,750 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
